Date: 2015-01-06
Type of information: Nomination
Compound:
Company: Immunomedics (USA - NJ)
Therapeutic area: Autoimmune diseases – Cancer - Oncology
Type agreement: nomination
Action mechanism:
Disease:
Details: * On January 6, 2015, Immunomedics announced the appointment of Francois E. Wilhelm, M.D., Ph.D., as Chief Medical Officer of the Company. Dr. Wilhelm is a seasoned R&D Senior Executive with significant experience in oncology and rheumatology in both the United States and Europe. Dr. Wilhelm most recently served as Chief Medical Officer and Senior Vice President at Onconova Therapeutics. Previously, he led clinical development programs at Fujisawa, Pfizer, Procter & Gamble, Akros Pharma, and Johnson and Johnson in the United
States, as well as Hoffmann-La Roche in Europe. Dr. Wilhelm is Board Certified in Rheumatology and received his M.D. from the University of Paris, France, where he also earned a Ph.D. in Endocrinology and a Master degree in Biostatistics. Dr. Wilhelm has presented at leading medical conferences and published extensively in major peer-reviewed journals.
Financial terms:
Latest news:
